Skip to main content

Table 3 Morphologic classification of HCM

From: Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy

 

Total

Group A

Group B

p-value

APH

21 (21%)

6 (25%)

15 (19%)

0.31

Type 1

7 (7%)

1 (4%)

6 (8%)

0.23

Type 2

4 (4%)

1 (4%)

3 (4%)

1.00

Type 3

61 (60%)

14 (59%)

47 (60%)

0.89

Type 4

9 (9%)

2 (8%)

7 (9%)

0.80

  1. APH, apical hypertrophy
  2. Type 1, basal septal hypertrophy
  3. Type 2, diffuse hypertrophy of the ventricular septum
  4. Type 3, diffuse hypertrophy of the ventricular septum and antero-lateral free wall
  5. Type 4, hypertrophy of the lateral wall